Nurse Practitioner · Sarasota, FL
NPI
1508215450
Since 2016
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
943 S Beneva Rd Ste 210
Sarasota, FL, 34232
Phone (941) 379-1777
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$5.1M
7,005 prescriptions
Company payments, 2025
$14K
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Stacy Centeno prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 916 prescriptions and refills. In total Stacy Centeno wrote 7,005 Medicare prescriptions that cost $5.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Mounjaro Tirzepatide | 916 | 1,139 | 193 | $1.2M |
| Ozempic Semaglutide | 626 | 1,013 | 165 | $958K |
| Metformin Hcl Generic | 404 | 1,203 | 132 | $3,211 |
| Levothyroxine Sodium Generic | 390 | 1,091 | 119 | $3,872 |
| Tresiba Flextouch U-200 Insulin Degludec | 367 | 911 | 118 | $514K |
| Metformin Hcl Er Metformin Hcl | 347 | 1,013 | 120 | $3,905 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 238 | 672 | 122 | $33K |
| Glimepiride Generic | 232 | 643 | 76 | $2,139 |
| Glipizide Er Glipizide | 229 | 606 | 79 | $3,310 |
| Glipizide Generic | 216 | 604 | 67 | $2,207 |
| Jardiance Empagliflozin | 184 | 510 | 69 | $287K |
| Rybelsus Semaglutide | 138 | 226 | 37 | $212K |
| Pioglitazone Hcl Generic | 132 | 373 | 41 | $1,091 |
| Trulicity Dulaglutide | 124 | 182 | 37 | $171K |
| Novolog Flexpen Insulin Aspart | 122 | 291 | 50 | $37K |
Brand drugs: 4,303 claims; generic drugs: 2,158 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stacy Centeno $14K ($14K in general payments such as food, travel and fees) from 10 companies. The largest payer was Dexcom, Inc. with $6,820.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 10 | $6,820 |
| Abbott Laboratories ABT | 20 | $6,540 |
| Novo Nordisk Inc NVO | 2 | $241 |
| Insulet Corporation PODD | 2 | $130 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $107 |
| Sequel Med Tech, LLC | 1 | $99.44 |
| Amgen Inc. AMGN | 2 | $31.23 |
| Beta Bionics, Inc. BBNX | 2 | $27.77 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $19.62 |
| Lilly USA, LLC LLY | 1 | $17.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.